Bulletin
Investor Alert

New York Markets After Hours

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 4:13 p.m.

/zigman2/quotes/200043077/composite

$

45.02

Change

0.00 0.00%

Volume

Volume 10,239

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 47.64

$ 45.02

Change

-2.62 -5.50%

Day low

Day high

$44.12

$47.67

Open

52 week low

52 week high

$43.81

$93.94

Open

Annual Financials for Denali Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue --129.16M26.68M335.66M
Cost of Goods Sold (COGS) incl. D&A 1.47M3.08M---
COGS excluding D&A -----
Depreciation & Amortization Expense 1.47M3.08M7.42M7.99M6.17M
Depreciation 1.47M3.08M7.42M7.99M6.17M
Amortization of Intangibles -----
Gross Income (1.47M)(3.08M)---
20162017201820192020 5-year trend
SG&A Expense 85.96M87.06M160.22M230.37M266.77M
Research & Development 74.23M71.38M135.28M191.88M212.62M
Other SG&A 11.73M15.68M24.93M38.49M54.16M
Other Operating Expense -----
Unusual Expense --8.1M1.3M(100,000)
EBIT after Unusual Expense --(46.57M)(212.98M)62.82M
Non Operating Income/Expense -----
Non-Operating Interest Income 781,0001.96M10.33M15.02M9.14M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (86.65M)(88.19M)(36.24M)(197.97M)71.96M
Income Tax ---(351,000)823,000
Income Tax - Current Domestic ----823,000
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (86.65M)(88.19M)(36.24M)(197.61M)71.14M
Minority Interest Expense -----
Net Income (86.65M)(88.19M)(36.24M)(197.61M)71.14M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (86.65M)(88.19M)(36.24M)(197.61M)71.14M
Preferred Dividends -----
Net Income Available to Common (86.65M)(88.19M)(36.24M)(197.61M)71.14M
EPS (Basic) (0.96)(5.89)(0.39)(2.07)0.65
Basic Shares Outstanding 90.06M14.96M92.62M95.61M108.97M
EPS (Diluted) (0.96)(5.89)(0.39)(2.07)0.63
Diluted Shares Outstanding 90.06M14.96M92.62M95.61M112.7M
EBITDA (85.96M)(87.06M)(31.06M)(203.69M)68.89M
Link to MarketWatch's Slice.